Literature DB >> 21488863

GPCR expression in tissues and cells: are the optimal receptors being used as drug targets?

P A Insel1, A Snead1, F Murray1, L Zhang1, H Yokouchi1, T Katakia1, O Kwon1, D Dimucci1, A Wilderman1.   

Abstract

G-protein-coupled receptors [GPCRs, also known as 7-transmembrane (7-TM) receptors] comprise the largest family of membrane receptors in humans and other species and, in addition, represent the greatest number of current drug targets. In this article, we review methods to define GPCR expression and data indicating that individual cells express >100 different GPCRs. Results from studies that have quantified expression of these receptors lead us to conclude that the optimal GPCRs may not be currently used as therapeutic targets. We propose that studies of GPCR expression in individual cells will likely reveal new insights regarding cellular physiology and therapeutic approaches. Findings that define and characterize the most highly expressed GPCRs thus have important potential in terms of identifying new drug targets and novel therapies directed at a wide range of clinical disorders.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21488863      PMCID: PMC3372817          DOI: 10.1111/j.1476-5381.2011.01434.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Global analysis of G-protein-coupled receptor signaling in human tissues.

Authors:  Yaron Hakak; Devin Shrestha; Moira C Goegel; Dominic P Behan; Derek T Chalmers
Journal:  FEBS Lett       Date:  2003-08-28       Impact factor: 4.124

2.  A polymorphism linked to bipolar affective disorder does not alter the CRE activity of constitutively activated trace amine receptor 4.

Authors:  J Reiners; M Schmidt; J Packer; L Unger; W Wernet
Journal:  Mol Psychiatry       Date:  2007-10       Impact factor: 15.992

Review 3.  Orphan GPCR research.

Authors:  S Chung; T Funakoshi; O Civelli
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

4.  Gene expression profiling of neuropeptides in mouse cerebellum, hippocampus, and retina.

Authors:  Kiyotaka Akiyama; Setsuko Nakanishi; Nozomu H Nakamura; Takayuki Naito
Journal:  Nutrition       Date:  2008-07-26       Impact factor: 4.008

5.  The G protein-coupled receptor repertoires of human and mouse.

Authors:  Demetrios K Vassilatis; John G Hohmann; Hongkui Zeng; Fusheng Li; Jane E Ranchalis; Marty T Mortrud; Analisa Brown; Stephanie S Rodriguez; John R Weller; Abbie C Wright; John E Bergmann; George A Gaitanaris
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 6.  Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

Authors:  P A Insel; L Zhang; F Murray; H Yokouchi; A C Zambon
Journal:  Acta Physiol (Oxf)       Date:  2011-05-26       Impact factor: 6.311

7.  Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase.

Authors:  James S Swaney; David M Roth; Erik R Olson; Jennifer E Naugle; J Gary Meszaros; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

8.  Anatomical profiling of G protein-coupled receptor expression.

Authors:  Jean B Regard; Isaac T Sato; Shaun R Coughlin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

9.  The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals.

Authors:  Utako Yokoyama; Hemal H Patel; N Chin Lai; Nakon Aroonsakool; David M Roth; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

10.  Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants.

Authors:  Mark Kidd; Irvin M Modlin; Bjorn I Gustafsson; Ignat Drozdov; Oyvind Hauso; Roswitha Pfragner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-06-12       Impact factor: 4.052

View more
  24 in total

1.  Themed section: molecular pharmacology of GPCRs.

Authors:  R J Summers
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  GPCRs in pulmonary arterial hypertension: tipping the balance.

Authors:  Jean Iyinikkel; Fiona Murray
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

Review 3.  Opportunities for functional selectivity in GPCR antibodies.

Authors:  David R Webb; Tracy M Handel; Anke Kretz-Rommel; Raymond C Stevens
Journal:  Biochem Pharmacol       Date:  2012-09-10       Impact factor: 5.858

Review 4.  G Protein-Coupled Receptor (GPCR) Expression in Native Cells: "Novel" endoGPCRs as Physiologic Regulators and Therapeutic Targets.

Authors:  Paul A Insel; Andrea Wilderman; Alexander C Zambon; Aaron N Snead; Fiona Murray; Nakon Aroonsakool; Daniel S McDonald; Shu Zhou; Thalia McCann; Lingzhi Zhang; Krishna Sriram; Amy M Chinn; Alexander V Michkov; Rebecca M Lynch; Aaron C Overland; Ross Corriden
Journal:  Mol Pharmacol       Date:  2015-03-03       Impact factor: 4.436

Review 5.  cAMP and Epac in the regulation of tissue fibrosis.

Authors:  Paul A Insel; Fiona Murray; Utako Yokoyama; Silvia Romano; Hongruo Yun; Loren Brown; Aaron Snead; David Lu; Nakon Aroonsakool
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Deletion of Gpr128 results in weight loss and increased intestinal contraction frequency.

Authors:  Ying-Yin Ni; Yan Chen; Shun-Yuan Lu; Bi-Ying Sun; Fang Wang; Xiao-Lin Wu; Su-Ying Dang; Guo-Hua Zhang; Hong-Xin Zhang; Yin Kuang; Jian Fei; Ming-Min Gu; Wei-Fang Rong; Zhu-Gang Wang
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 7.  Biophysical characterization of membrane proteins in nanodiscs.

Authors:  Sayaka Inagaki; Rodolfo Ghirlando; Reinhard Grisshammer
Journal:  Methods       Date:  2012-12-03       Impact factor: 3.608

8.  Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.

Authors:  Andrew J Haak; Enis Kostallari; Delphine Sicard; Giovanni Ligresti; Kyoung Moo Choi; Nunzia Caporarello; Dakota L Jones; Qi Tan; Jeffrey Meridew; Ana M Diaz Espinosa; Aja Aravamudhan; Jessica L Maiers; Rodney D Britt; Anja C Roden; Christina M Pabelick; Y S Prakash; Seyed Mehdi Nouraie; Xiaoyun Li; Yingze Zhang; Daniel J Kass; David Lagares; Andrew M Tager; Xaralabos Varelas; Vijay H Shah; Daniel J Tschumperlin
Journal:  Sci Transl Med       Date:  2019-10-30       Impact factor: 17.956

9.  The roles played by highly truncated splice variants of G protein-coupled receptors.

Authors:  Helen Wise
Journal:  J Mol Signal       Date:  2012-09-01

10.  Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis.

Authors:  Yafeng Ren; Yuwei Zhang; Lu Wang; Fuqian He; Mengli Yan; Xiaoheng Liu; Yangying Ou; Qinkai Wu; Tao Bi; Shiyuan Wang; Jian Liu; Bi-Sen Ding; Li Wang; Jie Qing
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.